Thomson sells data unit for $1.25B

Share this article:

Private-equity firm Veritas Capital will buy the healthcare business of Thomson Reuters for $1.25 billion in cash.

The sale, which was announced in late April, was expected to close in a few months. Thomson Reuters had re-launched a sales process for the unit earlier this year.

The healthcare business provides data, analytics and other services to companies, government agencies and healthcare professionals. Its brands include MarketScan, Advantage Suite, Micromedex, CareDiscovery and ActionOI, coupled with expert services and analysis.

CEO Mike Boswood will continue to be in charge of the business, said Veritas Capital's chairman, Robert McKeon, in a statement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Agency Gallery

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters